Literature DB >> 34697048

Educational intervention to improve appropriate digoxin therapeutic drug monitoring: a quasi-experimental study.

Seyma Oncu1, Anil Baskurt2, Bihter Senturk2, Ozgur Aslan2, Tuncay Kume3, Reyhan Ucku4, Ayse Gelal5.   

Abstract

OBJECTIVES: Our previous retrospecive study evaluating the appropriateness of serum digoxin concentration (SDC) measurements revealed errors in the timing of blood specimen collection in 98% of the tests. The aim of this study is to evaluate the appropriateness of the SDC measurements and the factors involved in inappropriate test-ordering, after training health personnel in digoxin therapeutic drug monitoring.
METHODS: This is a training-based quasi-experimental study. The residents and nurses of the Cardiology Clinic were trained first in December 2017, and refresher training courses were carried out every month throughout the study. The medical data of the inpatients receiving digoxin therapy were recorded prospectively, between January and December 2018. The appropriateness of the physicians' orders for SDC measurement was evaluated according to the criteria of the right indication and right timing of blood collection. The results are presented by descriptive statistics, Student's t-test and χ2 analysis.
RESULTS: A total of 232 SDC tests were ordered for 121 patients (age: 71.0±12.6 years, 56.2% women). Of these orders,129 (55.6%) were considered appropriate: 205 (88.4%) for indication and 129 (62.9%) for blood collection timing. There was a significant correlation between inappropriate order for SDC test and the age of the patient, female gender, impairment of renal function tests, high levels of serum BNP and the number of medications used (P<0.005).
CONCLUSIONS: Approximately a one-half decrease in inappropriate tests compared with our previous study results imply that education has a positive effect on physician behaviour. However, physicians' concerns due to increased risk factors for the patient still play a role in inappropriate test-ordering. © European Association of Hospital Pharmacists 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  digoxin; education; heart failure; serum digoxin concentration; therapeutic drug monitoring

Mesh:

Substances:

Year:  2019        PMID: 34697048      PMCID: PMC8552125          DOI: 10.1136/ejhpharm-2019-002078

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  27 in total

1.  The impact of an educational intervention, the New GP Contract and NICE guidelines on anti-epilepsy therapeutic drug monitoring.

Authors:  I Minshall; D Berry; D Smith
Journal:  Seizure       Date:  2010-11-23       Impact factor: 3.184

2.  Evaluating the appropriateness of digoxin level monitoring.

Authors:  F Cañas; M J Tanasijevic; N Ma'luf; D W Bates
Journal:  Arch Intern Med       Date:  1999-02-22

Review 3.  Cost-effectiveness of therapeutic drug monitoring: a systematic review.

Authors:  D J Touw; C Neef; A H Thomson; A A Vinks
Journal:  Ther Drug Monit       Date:  2005-02       Impact factor: 3.681

4.  Inappropriate digoxin monitoring.

Authors:  R J Copeland; H Thorpe; E A Kay
Journal:  J Clin Pharm Ther       Date:  1992-06       Impact factor: 2.512

5.  Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update.

Authors:  Mate Vamos; Julia Wiebke Erath; Alexander Philipp Benz; Renato Delascio Lopes; Stefan Hans Hohnloser
Journal:  Am J Cardiol       Date:  2018-10-04       Impact factor: 2.778

Review 6.  Differential pharmacokinetics of digoxin in elderly patients.

Authors:  C G Hanratty; P McGlinchey; G D Johnston; A P Passmore
Journal:  Drugs Aging       Date:  2000-11       Impact factor: 3.923

7.  Effect of education on the appropriateness of serum drug concentration determination.

Authors:  D J Carroll; G E Austin; G V Stajich; R K Miyahara; J E Murphy; E S Ward
Journal:  Ther Drug Monit       Date:  1992-02       Impact factor: 3.681

8.  Digoxin toxicity: an evaluation in current clinical practice.

Authors:  K M Williamson; K A Thrasher; K B Fulton; N M LaPointe; G D Dunham; A A Cooper; P S Barrett; J H Patterson
Journal:  Arch Intern Med       Date:  1998 Dec 7-21

9.  Appropriateness of digoxin measurement in hospitalized patients.

Authors:  Seyma Oncu; Ayse Gelal; Ozgur Aslan; Reyhan S Ucku
Journal:  Biochem Med (Zagreb)       Date:  2017-11-24       Impact factor: 2.313

Review 10.  Overview of therapeutic drug monitoring.

Authors:  Ju Seop Kang; Min Ho Lee
Journal:  Korean J Intern Med       Date:  2009-03       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.